Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Front Immunol ; 12: 737601, 2021.
Article in English | MEDLINE | ID: mdl-34867959

ABSTRACT

In the present study, the modulation of the transcriptional immune response (microarray analysis) in the head kidney (HK) of the anadromous fish Atlantic salmon (Salmo salar) fed a diet supplemented with an olive fruit extract (AQUOLIVE®) was evaluated. At the end of the trial (133 days), in order to investigate the immunomodulatory properties of the phytogenic tested against a bacterial infection, an in vivo challenge with Aeromonas salmonicida was performed. A total number of 1,027 differentially expressed genes (DEGs) (805 up- and 222 downregulated) were found when comparing the transcriptomic profiling of the HK from fish fed the control and AQUOLIVE® diets. The HK transcripteractome revealed an expression profile that mainly favored biological processes related to immunity. Particularly, the signaling of i-kappa B kinase/NF-kappa and the activation of leukocytes, such as granulocytes and neutrophils degranulation, were suggested to be the primary actors of the innate immune response promoted by the tested functional feed additive in the HK. Moreover, the bacterial challenge with A. salmonicida that lasted 12 days showed that the cumulative survival was higher in fish fed the AQUOLIVE® diet (96.9 ± 6.4%) than the control group (60.7 ± 13.5%). These results indicate that the dietary supplementation of AQUOLIVE® at the level of 0.15% enhanced the systemic immune response and reduced the A. salmonicida cumulative mortality in Atlantic salmon smolts.


Subject(s)
Fish Diseases/immunology , Fish Diseases/prevention & control , Furunculosis/immunology , Furunculosis/prevention & control , Olea/chemistry , Phytotherapy/veterinary , Salmo salar/immunology , Salmo salar/microbiology , Aeromonas salmonicida/immunology , Aeromonas salmonicida/pathogenicity , Animals , Fish Diseases/microbiology , Furunculosis/microbiology , Gene Expression Profiling , Head Kidney/drug effects , Head Kidney/immunology , Immunity, Innate/drug effects , Immunity, Innate/genetics , Plant Extracts/administration & dosage , Plant Extracts/chemistry , Polyphenols/administration & dosage , Salmo salar/genetics , Triterpenes/administration & dosage
2.
Front Immunol ; 12: 693613, 2021.
Article in English | MEDLINE | ID: mdl-34295335

ABSTRACT

ß-glucans are prebiotic and/or food additives used by the aquaculture industry to enhance the immune response of fish. Their efficiency may vary according to their origin and structure. In this study, the immunostimulant effects of two ß-glucan types extracted from wild-type baker's yeast (Saccharomyces cerevisiae) and its null-mutant Gas1 were investigated. Gas1 has a beta-1,3-glucanosyltransferase activity necessary for cell wall assembly. Using a positive (commercial product MacroGard®) and a negative control (a diet without glucans), we evaluated the immune responses and disease resistance of rainbow trout juveniles (mean weight, ~44 g) fed control, low (0.2%) and high (0.5%) doses of Macrogard®, Gas1, and Wild type-ß-glucan after a short-term (15 days, D15) or mid-term (36 days, D36) feeding periods. We found that ß-glucan supplemented diets did not affect growth performance, mortality, splenic index, or leukocyte respiratory burst activity on D15 nor D36. However, each ß-glucan triggered different immune effectors, depending of the doses or length of exposure compared to others and/or the negative control. Indeed, high dose of MacroGard® significantly increased lysozyme activities at D15 compared with the control and other diets (p<0.05). At D36, MacroGard ß-glucan enhanced the production of lymphocytes in comparison with the control diet (p<0.05). Regarding WT ß-glucan, at D36, WT-ß-glucan, especially the high dose, provided the highest enzymatic activities (lysozyme and ACH50) and Ig level (p<0.01). Furthermore, on D36, Gas1 also increased lysozyme activity, Ig proportion, and some immune genes (mcsfra, hepcidin) compared with MacroGard® (p<0.05). Besides, both doses of Gas1-ß-glucans increased the resistance of juveniles to bacterial infection highlighted by a higher survival rate at 14 days post-challenge compared with the control and other types and doses of ß-glucans (p<0.05). In conclusion, our results suggest that Gas1-ß-glucan could represent a promising immunostimulant that would help to prevent diseases in aquaculture even more efficiently than other ß-glucans already in use. Mode of action and particular efficiency of this new Gas1 mutant are debated.


Subject(s)
Adjuvants, Immunologic/pharmacology , Aeromonas salmonicida/pathogenicity , Dietary Supplements , Furunculosis/prevention & control , Gram-Negative Bacterial Infections/veterinary , Oncorhynchus mykiss/microbiology , beta-Glucans/pharmacology , Aeromonas salmonicida/immunology , Animal Feed , Animals , Antimicrobial Cationic Peptides/metabolism , Fisheries , Furunculosis/immunology , Furunculosis/microbiology , Gram-Negative Bacterial Infections/immunology , Gram-Negative Bacterial Infections/microbiology , Gram-Negative Bacterial Infections/prevention & control , Immunity, Humoral/drug effects , Inflammation Mediators/metabolism , Leukocytes/drug effects , Leukocytes/immunology , Leukocytes/metabolism , Oncorhynchus mykiss/immunology , Oncorhynchus mykiss/metabolism , Time Factors
3.
J Appl Microbiol ; 129(1): 137-145, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32119179

ABSTRACT

AIMS: This study aimed to evaluate in vitro efficacy of essential oils (EOs) and their compounds (EOCs) alone or in combination against Aeromonas salmonicida subsp. salmonicida, the causative agent of furunculosis in salmonid fish. METHODS AND RESULTS: Antimicrobial activity of 13 EOs and 16 EOCs was investigated for four A. salmonicida subsp. salmonicida strains using broth microdilution. The checkerboard assay was used to evaluate a putative synergy between the most efficient EOs and EOCs against the tested strains. Cinnamon bark, oregano, clove, and thyme oils and their major compounds cinnamaldehyde, eugenol, carvacrol and thymol showed the lower minimum inhibitory concentration and minimum bactericidal concentration values. The association of cinnamaldehyde and eugenol (V/V: 30%/70%) showed a synergistic activity against three tested strains. The combinations of cinnamon with oregano, clove or thyme EOs showed a neutral or additive activity against all the tested strains. CONCLUSIONS: Cinnamon, oregano, clove and thyme oils and their major phytochemical compounds showed strong activities against A. salmonicida subsp. salmonicida strains. SIGNIFICANCE AND IMPACT OF THE STUDY: To reduce the use of antibiotics in aquaculture, phytochemicals such as cinnamaldehyde and eugenol can be tested alone or in combination in in vivo studies as functional feed alternatives.


Subject(s)
Aeromonas salmonicida/drug effects , Anti-Bacterial Agents/pharmacology , Oils, Volatile/pharmacology , Phytochemicals/pharmacology , Animals , Drug Synergism , Furunculosis/microbiology , Microbial Sensitivity Tests , Oils, Volatile/chemistry , Plant Oils/chemistry , Plant Oils/pharmacology , Salmonidae/microbiology
4.
PLoS One ; 13(12): e0209381, 2018.
Article in English | MEDLINE | ID: mdl-30571741

ABSTRACT

The following research was conducted to elucidate the evolution and expression of salmonid selenoprotein P (SelP), a selenoprotein that is unique in having multiple selenocysteine (Sec) residues, following supranutritional selenium supplementation and infection in rainbow trout. We show that in salmonids SelP is present as four paralogues and that the diversification of SelP genes during vertebrate evolution relates to whole genome duplication events. With 17 and 16 selenocysteine residues for rainbow trout (Oncorhynchus mykiss)/Atlantic salmon (Salmo salar) SelPa1 and SelPa2 proteins respectively and 1 or 2 (trout or salmon) and 4 or 3 (trout or salmon) selenocysteine residues for salmonid SelPb1 and SelPb2 proteins respectively, this is the highest number of (predicted) multiple selenocysteine containing SelP proteins reported for any vertebrate species to date. To investigate the effects of selenium form on SelP expression we added different concentrations (1 nM- 10 µM) of organic or inorganic selenium to a trout cell line (RTG-2 cells) and analysed changes in mRNA abundance. We next studied the impact of supplementation on the potential modulation of these transcripts by PAMPs and proinflammatory cytokines in RTG-2 and RTS-11 cells. These experiments revealed that selenium type influenced the responses, and that SelP gene subfunctionalisation was apparent. To get an insight into the expression patterns in vivo we conducted a feeding trial with 2 diets differing in selenium content and 5 weeks later challenged the trout with a bacterial pathogen (Aeromonas salmonicida). Four tissues were analysed for SelP paralogue expression. The results show a significant induction of SelPa1 in gills and intestine following infection in selenium supplemented fish and for SelPa2 in gills. SelPb1 was significantly reduced in head kidney of both diet groups following infection, whilst SelPb2 was significantly upregulated in skin of both diet groups post infection. Overall these findings reveal differential expression profiles for the SelPa/SelPb paralogues in trout, influenced by selenium supply, cell type/tissue and stimulant. The increase of multiple Sec containing SelP proteins in salmonids could indicate an enhanced requirement for selenium in this lineage.


Subject(s)
Antioxidants/administration & dosage , Oncorhynchus mykiss/genetics , Salmo salar/genetics , Selenium/administration & dosage , Selenoprotein P/genetics , Aeromonas salmonicida/immunology , Aeromonas salmonicida/pathogenicity , Amino Acid Sequence/genetics , Animal Feed , Animals , Aquaculture/methods , Cell Line , Furunculosis/immunology , Furunculosis/microbiology , Furunculosis/prevention & control , Gene Duplication/genetics , Gene Duplication/immunology , Gram-Negative Bacterial Infections/immunology , Gram-Negative Bacterial Infections/microbiology , Gram-Negative Bacterial Infections/prevention & control , Gram-Negative Bacterial Infections/veterinary , Host-Pathogen Interactions/drug effects , Host-Pathogen Interactions/genetics , Host-Pathogen Interactions/immunology , Oncorhynchus mykiss/metabolism , Oncorhynchus mykiss/microbiology , RNA, Messenger/metabolism , Salmo salar/metabolism , Salmo salar/microbiology , Selenocysteine/genetics , Selenoprotein P/immunology , Selenoprotein P/metabolism , Up-Regulation/drug effects
5.
Fish Shellfish Immunol ; 59: 83-94, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27742588

ABSTRACT

Juvenile salmon, with an initial weight of 9 g, were fed three experimental diets, formulated to replace 35 (SPC35), 58 (SPC58) and 80 (SPC80) of high quality fishmeal (FM) with soy protein concentrate (SPC) in quadruplicate tanks. Higher dietary SPC inclusion was combined with increased supplementation of methionine, lysine, threonine and phosphorus. The experiment was carried out for 177 days. On day 92 salmon in each tank were bulk weighed. Post weighing eighty salmon from each tank were redistributed in two sets of 12 tanks. Salmon from the first set of tanks were vaccinated, while the second group was injected with phosphate buffer saline (PBS). Salmon were sampled on day 92 (pre-vaccination), day 94 (2 days post vaccination [dpv]/PBS injection [dpPBSinj]) and day 154 (62 dpv/dpPBSinj) of the trial for the assessment of their immune responses, prior to the performance of salmon bulk weights for each tank. On day 154, fish from each tank were again bulk weighed and then seventeen salmon per tank were redistributed in two sets of twelve tanks and intra-peritoneally infected with Aeromonas salmonicida. At Day 154, SPC80 demonstrated lower performance (weight gain, specific growth rate and thermal growth coefficient and feed conversion ratio) compared to SPC35 salmon. Reduced classical and total complement activities for salmon fed diets with over 58% of protein from SPC, were demonstrated prior to vaccination. Reduced alternative complement activity was detected for both SPC58 and SPC80 salmon at 2 dpv and for the SPC80 group at 62 dpv. Total and classical complement activities demonstrated no differences among the dietary groups after vaccination. Numerical increases in classical complement activity were apparent upon increased dietary SPC levels. Increased phagocytic activity (% phagocytosis and phagocytic index) was exhibited for the SPC58 group compared to SPC35 salmon at 62 dpPBSinj. No differences in serum lysozyme activity, total IgM, specific antibodies, protein, glucose and HKM respiratory burst were detected among the dietary groups at any timepoint or state. Mortalities as a result of the experimental infection only occurred in PBS-injected fish. No differences in mortality levels were demonstrated among the dietary groups. SPC58 diet supported both good growth and health in juvenile Atlantic salmon while SPC80 diet did not compromise salmon' immunity or resistance to intraperitoneally inflicted furunculosis.


Subject(s)
Diet/veterinary , Dietary Proteins , Furunculosis/prevention & control , Immunity, Innate , Salmo salar , Vaccination/veterinary , Aeromonas salmonicida/physiology , Amino Acids/immunology , Animal Feed/analysis , Animals , Dietary Proteins/immunology , Disease Resistance , Dose-Response Relationship, Drug , Furunculosis/immunology , Furunculosis/microbiology , Lysine/administration & dosage , Methionine/administration & dosage , Phosphates/immunology , Random Allocation , Soybean Proteins/immunology
6.
Clin Infect Dis ; 53(8): 787-92, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21921222

ABSTRACT

BACKGROUND: Pedicure-associated nontuberculous mycobacterial furunculosis has been reported in the setting of either outbreaks or sporadic case reports. The epidemiology of these infections is not well understood. METHODS: Systematic surveillance for pedicure-associated nontuberculous mycobacterial furunculosis was conducted in 2 North Carolina counties from 1 January 2005 through 31 December 2008. A subset of implicated nail salons and control salons was inspected and sampled for nontuberculous mycobacteria. RESULTS: Forty cases of suspected or confirmed pedicure-associated nontuberculous mycobacterial furunculosis were reported during the 4-year study period. Furunculosis incidence in the surveillance region was 1.00, 0.96, 0.83, and 0.89 cases per 100,000 population in 2005, 2006, 2007, and 2008, respectively. The responsible organisms primarily belonged to the Mycobacterium chelonae/abscessus group (30 [91%] of 33 isolates). Thirteen implicated salons and 11 control salons were visited and environmentally sampled. An assortment of nontuberculous mycobacteria was cultured from footbaths, but there was no association between the species distribution of the environmental isolates and implication of the salon in human infection. Evidence of suboptimal cleaning (visible debris or surface biofilms) was observed in at least 1 footbath for 11 of 13 implicated salons and 4 of 11 control salons (P = .032). CONCLUSIONS: Pedicure-associated mycobacterial furunculosis was endemic in these 2 North Carolina counties during 2005-2008. Suboptimal footbath cleaning may have contributed to these infections, which suggests straightforward means of potential prevention. The relative rarity of this type of infection in the setting of nearly ubiquitous exposure to these pathogens suggests that as yet undefined host-specific or procedure-related factors may be involved in susceptibility to these infections.


Subject(s)
Furunculosis/epidemiology , Hydrotherapy/adverse effects , Mycobacterium Infections, Nontuberculous/epidemiology , Nontuberculous Mycobacteria/isolation & purification , Adolescent , Adult , Beauty Culture , Endemic Diseases , Female , Furunculosis/microbiology , Furunculosis/transmission , Humans , Incidence , Male , Middle Aged , Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium Infections, Nontuberculous/transmission , Mycobacterium chelonae/isolation & purification , North Carolina/epidemiology , Population Surveillance , Risk Factors , Young Adult
7.
J Dermatolog Treat ; 18(2): 105-8, 2007.
Article in English | MEDLINE | ID: mdl-17520467

ABSTRACT

BACKGROUND: Chronic furunculosis is a recurrent staphylococcal abscess of the hair follicle. Besides ensuring personal hygiene, the management consists of long-term treatment with topical and systemic antibiotics. OBJECTIVE: An open-labeled, prospective study was conducted to assess the clinical and in vitro efficacy of azithromycin in the long-term suppressive treatment of chronic furunculosis. METHODS: Patients with a history of three or more episodes of furuncles were assigned to receive 12 weeks of suppressive treatment with azithromycin at a weekly dosage of 500 mg. In vitro susceptibility of azithromycin was evaluated with E-test. The primary efficacy parameter was complete absence of furuncles during the 3 months of azithromycin treatment. The secondary efficacy parameter was further absence of furuncles during the 3-month follow-up period. RESULTS: At the end of 3 months of therapy, azithromycin was found to be effective in 19 (79.2%) of 24 patients; 18 of these patients remained in remission during the 3 months of follow-up. All of the strains were methicillin-sensitive. The results of the E-test showed that 15 of 18 strains (83.3%) were susceptible to azithromycin. CONCLUSION: The results of this study indicate that azithromycin is an effective and safe alternative in the treatment of chronic furunculosis caused by methicillin-sensitive Staphylococcus aureus.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Azithromycin/therapeutic use , Furunculosis/drug therapy , Administration, Oral , Adolescent , Adult , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/pharmacology , Azithromycin/administration & dosage , Azithromycin/pharmacology , Chronic Disease , Drug Administration Schedule , Female , Furunculosis/microbiology , Furunculosis/pathology , Humans , Male , Methicillin Resistance , Microbial Sensitivity Tests , Middle Aged , Prospective Studies , Severity of Illness Index , Staphylococcus aureus/drug effects , Treatment Outcome
8.
Clin Infect Dis ; 44(11): e88-95, 2007 Jun 01.
Article in English | MEDLINE | ID: mdl-17479931

ABSTRACT

BACKGROUND: Skin infections due to Staphylococcus aureus have recently become a public concern, mainly because of emerging resistance against widely used antibiotics and specific virulence determinants. Strains harboring the lukS-lukF gene (which codes for Panton-Valentine leukocidin) are frequently associated with severe furunculosis. Generally applicable strategies for the control of community outbreaks of furunculosis have not been defined. METHODS: We report the investigation and successful termination of an outbreak of furunculosis due to lukS-lukF-positive S. aureus in a German village (n=144). Nasal swab specimens were obtained from village residents. A retrospective cohort study was conducted. Nasally colonized persons, persons who had current furuncles or who had experienced relapsing furuncles since 2002, and their family members underwent stringent decolonization measures using mupirocin nasal ointment and disinfecting wash solution. Multiple nasal swab specimens were obtained to monitor the long-term outcome of decolonization measures. RESULTS: From January 1998 through December 2004, 42 cases and 59 relapses of furunculosis were identified by active case finding. Of 140 participants tested, 51 (36%) were found to be nasally colonized with S. aureus. In 9 participants, the strain was positive for lukS-lukF. No methicillin resistance was detected. Risk of furunculosis was associated with contact with case patients (relative risk, 6.8; 95% confidence interval, 3.2-14.3) and nasal colonization with a lukS-lukF-positive strain of S. aureus (relative risk, 3.6; 95% confidence interval, 2.3-5.9). Passive surveillance implemented in January 2005 did not detect any case of lukS-lukF-positive, S. aureus-associated furuncles in this village. CONCLUSION: This report describes a successful strategy for terminating the transmission of epidemic strains of S. aureus among a nonhospitalized population.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Disease Outbreaks/prevention & control , Furunculosis/drug therapy , Furunculosis/epidemiology , Mupirocin/therapeutic use , Adolescent , Adult , Aged , Aged, 80 and over , Bacterial Proteins/genetics , Child , Child, Preschool , Cohort Studies , Drug Resistance, Bacterial , Female , Furunculosis/microbiology , Germany , Humans , Infant , Infant, Newborn , Leukocidins/genetics , Male , Methicillin Resistance , Microbial Sensitivity Tests , Middle Aged , Mupirocin/administration & dosage , Retrospective Studies , Risk Factors , Staphylococcus aureus/drug effects , Staphylococcus aureus/genetics , Staphylococcus aureus/isolation & purification , Treatment Outcome
10.
J Clin Microbiol ; 42(4): 1813-7, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15071058

ABSTRACT

We report two cases of lower-extremity furunculosis caused by Mycobacterium mageritense. Both patients were patrons of the same nail salon, where they received footbaths prior to pedicures. M. mageritense bacteria isolated from two whirlpool footbaths were determined to be closely related to the patient isolates by pulsed-field gel electrophoresis.


Subject(s)
Beauty Culture , Furunculosis/microbiology , Mycobacterium Infections/microbiology , Mycobacterium/isolation & purification , Nails , Adult , Electrophoresis, Gel, Pulsed-Field , Female , Humans , Hydrotherapy , Middle Aged , Mycobacterium/genetics
11.
Arch Dermatol ; 139(5): 629-34, 2003 May.
Article in English | MEDLINE | ID: mdl-12756100

ABSTRACT

BACKGROUND: Rapidly growing mycobacteria (RGM) can cause a variety of cutaneous and systemic diseases. The causative organisms are typically Mycobacterium fortuitum or Mycobacterium chelonae (also known as Mycobacterium abscessus). Primary cutaneous lesions may develop after a variable latent period, from weeks to several months, and usually result from direct inoculation after trauma, from injections, or during surgery via contaminated medical instruments. Recently, investigators from the Centers for Disease Control and Prevention, Atlanta, Ga, and the California Department of Health Services, Berkeley, documented a large, unprecedented outbreak of community-acquired RGM infection, during which more than 100 patrons of a northern California nail salon contracted furunculosis in their legs as a result of exposure to whirlpool footbaths that were contaminated with M fortuitum. OBSERVATIONS: We report the clinical and epidemiological findings in 3 cases of lower extremity RGM infections that occurred after similar whirlpool footbath exposure at several different nail salons in southern California. These infections typically presented as recurrent furunculosis, causing considerable morbidity as a result of scarring, delayed diagnosis, and the need for long-term polymicrobial therapy. CONCLUSIONS: Rapidly growing mycobacterial infections related to pedicures may continue to occur in a sporadic fashion. Clinicians should consider the possibility of RGM infection and inquire about recent pedicures in a patient with recurrent lower extremity furunculosis and abscesses that are unresponsive to conventional antibiotic therapy.


Subject(s)
Furunculosis/etiology , Hydrotherapy/adverse effects , Mycobacterium Infections, Nontuberculous/etiology , Mycobacterium chelonae/growth & development , Mycobacterium fortuitum/growth & development , Adult , Child , Female , Furunculosis/microbiology , Furunculosis/pathology , Humans , Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium Infections, Nontuberculous/pathology , Mycobacterium chelonae/isolation & purification , Mycobacterium fortuitum/isolation & purification , Time Factors
12.
Med Dosw Mikrobiol ; 47(3-4): 127-32, 1995.
Article in Polish | MEDLINE | ID: mdl-8833923

ABSTRACT

Autovaccine was prepared for 268 patients treated for: osteomyelitis--95, acne--63, furunculosis--53, and other pyogenic infections--57 patients. 540 bacterial strains were isolated from the specimens obtained from patients. 170 Staphylococcus aureus strains were cultured, what represents 31.5% of the isolated strains. Isolated Staphylococcus aureus strains were most often penicillin-resistant (91.5%), amplicillin-resistant (86%), less frequently tetracycline-resistant (73%), and doxycycline-resistant (53.1%). Staphylococcus aureus strains isolated from outpatients were found to be less resistant to particular antibiotics as compared to the group of strains isolated from the inpatients receiving treatment in different hospital departments. 13.5% of studied Staphylococcus aureus strains were methicillin-resistant.


Subject(s)
Acne Vulgaris/therapy , Immunotherapy, Active , Staphylococcal Infections/therapy , Staphylococcus aureus/drug effects , Suppuration/microbiology , Acne Vulgaris/microbiology , Bacterial Vaccines/therapeutic use , Drug Resistance, Microbial , Furunculosis/microbiology , Furunculosis/therapy , Humans , Microbial Sensitivity Tests , Osteomyelitis/microbiology , Species Specificity , Staphylococcus aureus/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL